Abstract
Unfavourable results and shortage of donor organs have led to restricted indication of liver transplantation for irresectable hepatocellular carcinoma. This review analyses the current state of experience in order to work out criteria for a more differentiated multimodal treatment including liver transplantation. New techniques of extended liver resection under hypothermic perfusion have to be considered in some conventionally irresectable tumors. Split-liver transplantation is a donor organ saving option which preserves the chance of transplantation in individual tumor patients without disadvantage for patients with benign diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
